Physician profile
Debra A Kramer
NPI 1659360923
$5,258.37
in general payments reported to CMS, 2019-2025
33 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,539 · 2022: $1,481 · 2023: $1,025 · 2024: $936 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,153 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,153.42 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipla USA INC. | $793.90 | 2021 | |
| Axonics, INC. | $756.41 | 2021-2023 | Axonics, Bulkamid |
| Astellas Pharma US INC | $599.71 | 2021-2023 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $498.98 | 2021-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $405.18 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $372.05 | 2021-2024 | |
| Urovant Sciences INC | $179.07 | 2021-2022 | |
| Urogen Pharma, INC. | $166.75 | 2022-2024 | Jelmyto |
| 180 Medical, INC. | $164.08 | 2022-2025 | |
| Medtronic, INC. | $142.49 | 2022-2025 | Interstim |
| Convatec INC. | $128.27 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.93 | 2021-2023 | |
| Pfizer INC. | $116.96 | 2021-2025 | |
| Tolmar, INC. | $89.88 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $84.48 | 2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $82.77 | 2021-2024 | Speedicath |
| Dentsply Ih INC. | $65.16 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $55.94 | 2022-2023 | Lynparza |
| Teleflex LLC | $53.50 | 2021-2023 | Urolift |
| Calyxo, INC. | $48.62 | 2024 | Cvac Aspiration System |
| Dentsply Ih Ab | $47.34 | 2024-2025 | Lofric |
| Tempus Ai, INC | $29.66 | 2024 | |
| Blue Earth Diagnostics | $29.22 | 2021 | |
| Myovant Sciences INC. | $29.19 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $26.93 | 2025 | Austedo Xr |
| Clarus Therapeutics INC. | $23.42 | 2021 | |
| Progenics Pharmaceuticals, INC. | $23.18 | 2023 | Pylarify |
| Verity Pharmaceuticals INC. | $23.12 | 2025 | Trelstar |
| Endo USA, INC. | $23.06 | 2025 | Xiaflex |
| E.R. Squibb & Sons, L.L.C. | $20.87 | 2022 | |
| Merck Sharp & Dohme LLC | $18.76 | 2021 | |
| Accord Healthcare, INC. | $18.43 | 2022 | |
| Foundation Medicine, INC. | $14.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.